Business Context and Reporting Period
Weave Communications, Inc. (WEAV) is a vertical Software-as-a-Service (SaaS) platform providing AI-powered patient engagement and payment solutions for small and medium-sized healthcare practices. This Form 10-Q covers the quarterly period ended September 30, 2025. The Company is classified as an emerging growth company and an accelerated filer.
Key Financial Metrics
| Metric | Q3 2025 | Q3 2024 | 9M 2025 | 9M 2024 |
|---|---|---|---|---|
| Revenue | $61.3 million | $52.4 million | $175.6 million | $150.1 million |
| Gross Profit | $44.3 million | $37.7 million | $126.2 million | $106.8 million |
| Gross Margin | 72% | 72% | 72% | 71% |
| Net Loss | $(8.7) million | $(5.9) million | $(26.2) million | $(21.6) million |
| Operating Cash Flow | $6.1 million | $4.5 million | $11.3 million | $7.5 million |
| Free Cash Flow | $5.0 million | $3.5 million | $8.5 million | $4.2 million |
| Cash & Equivalents | $64.4 million | $51.6 million | $64.4 million | $51.1 million |
| Short-term Investments | $15.9 million | $47.5 million | $15.9 million | $47.5 million |
| Debt | $0 outstanding | $0 outstanding | $0 outstanding | $0 outstanding |
Note: The Company maintains a $50.0 million revolving line of credit with no outstanding borrowings as of September 30, 2025.
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 17% year-over-year for both the quarter and the nine-month period. Growth was driven by approximately $8.5 million (Q3) and $19.8 million (9M) from new customer locations, with the remainder from existing customer expansion.
- Operating Expenses: Total operating expenses increased 20% in Q3 and 18% in the 9M period.
- Sales & Marketing: Increased 25% (Q3) and 20% (9M) due to higher personnel costs, commissions, and demand generation spend.
- R&D: Increased 33% (Q3) and 23% (9M), largely driven by salary increases and stock-based compensation related to the TrueLark acquisition.
- Acquisition Activity: In May 2025, the Company acquired Vidurama, Inc. ("TrueLark") for total consideration of $35.9 million. This resulted in $29.5 million of goodwill and $8.0 million of identifiable intangible assets. The acquisition contributed to increased R&D and G&A expenses.
- Investment Portfolio: Short-term investments decreased significantly from $47.5 million to $15.9 million, primarily due to maturities and cash used to fund the TrueLark acquisition.
Guidance, Outlook, and Risks
- Outlook: Management expects operating cash flows to improve as the Company scales. The Company is focusing on expanding into medium-sized businesses and new healthcare verticals using its enhanced platform and the TrueLark acquisition.
- Non-GAAP Measures: Adjusted EBITDA for the nine months ended September 30, 2025, was $4.7 million, compared to $1.9 million in the prior year period.
- Key Risks:
- Customer Concentration: The business relies heavily on small and medium-sized businesses (SMBs), which are more susceptible to economic downturns and higher churn rates.
- Third-Party Dependencies: Significant reliance on Google Cloud Platform (GCP) for infrastructure and Stripe for payment processing. Disruptions to these providers could materially impact operations.
- Regulatory Compliance: Subject to evolving regulations regarding VoIP, data privacy (HIPAA), and text messaging (TCPA/10DLC), which could increase costs or limit functionality.
- Profitability: The Company has a history of losses with an accumulated deficit of $317.2 million and may not achieve or sustain profitability in the future.
Investor Verification Checklist
- Retention Metrics: Verify the Dollar-Based Net Revenue Retention Rate (94% as of Sept 30, 2025) and Gross Revenue Retention Rate (90%) to assess customer stickiness.
- Acquisition Integration: Monitor the integration of TrueLark and the realization of synergies, particularly regarding the $5.0 million potential performance-based payouts to key employees.
- Liquidity Position: Confirm the Company maintains the $20.0 million minimum liquidity covenant required by its SVB credit facility if cash and short-term investments fall below $100 million.
- Stock-Based Compensation: Review the $28.2 million stock-based compensation expense for the nine months ended Sept 30, 2025, and the $56.4 million of unrecognized expense remaining.
- Deferred Revenue: Analyze the $38.5 million deferred revenue balance as an indicator of future revenue visibility.